Harel Insurance Investments & Financial Services Ltd. - VASCULAR BIOGENICS LTD ownership

VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 32 filers reported holding VASCULAR BIOGENICS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Harel Insurance Investments & Financial Services Ltd. ownership history of VASCULAR BIOGENICS LTD
ValueSharesWeighting
Q3 2023$30.0%11,0000.0%0.00%
Q2 2023$3
+50.0%
11,0000.0%0.00%
Q1 2023$2
+100.0%
11,0000.0%0.00%
Q4 2022$1
-100.0%
11,0000.0%0.00%
Q3 2022$2,000
-88.9%
11,0000.0%0.00%
Q2 2022$18,000
-5.3%
11,0000.0%0.00%
Q1 2022$19,000
-95.0%
11,000
-94.3%
0.00%
-100.0%
Q4 2021$382,000194,0000.01%
Other shareholders
VASCULAR BIOGENICS LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Lion Point Capital, LP 2,593,286$5,108,0001.37%
Ikarian Capital, LLC 790,838$1,558,0000.23%
Telemetry Investments, L.L.C. 70,000$138,0000.18%
PVG ASSET MANAGEMENT CORP 12,365$24,359,0000.09%
DLD Asset Management, LP 425,000$837,0000.04%
Phoenix Holdings Ltd. 1,020,000$2,009,0000.03%
Spectrum Planning & Advisory Services Inc. 16,000$32,0000.03%
ARK Investment Management 1,330,206$2,621,0000.01%
Harel Insurance Investments & Financial Services Ltd. 194,000$382,0000.01%
Total Clarity Wealth Management, Inc. 4,000$8,0000.00%
View complete list of VASCULAR BIOGENICS LTD shareholders